New Drug Application for Epsolay (5% encapsulated benzoyl peroxide cream) for the treatment of inflammatory lesions of rosacea submitted to FDA

The encapsulation of benzoyl peroxide is designed to deliver an effective dose to the skin, while reducing its ability to induce skin irritation. The filing is based on two 12-week placebo-controlled Phase III RCTs in people with papulopustular rosacea (n=733).


Biospace Inc.